Prescription Required
Inclusive of all taxes
In Infertility Coedhea Forte Soft Gelatin Capsule is a nutritional supplement that is used with other medicines in the treatment of infertility in females. It is rich in antioxidants and reduces the harmful effects of problems related to the reproductive system. It improves the level of female sex hormones in the body that is essential for the production and development of healthy eggs. This helps enhance fertility and increases the chance of a successful pregnancy.
It is unsafe to consume alcohol with Coedhea Forte Soft Gelatin Capsule.
Information regarding the use of Coedhea Forte Soft Gelatin Capsule during pregnancy is not available. Please consult your doctor.
Coedhea Forte Soft Gelatin Capsule is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Coedhea Forte Soft Gelatin Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
There is limited information available on the use of Coedhea Forte Soft Gelatin Capsule in patients with kidney disease. Please consult your doctor. However, based on the limited information available it is advised that Coedhea Forte Soft Gelatin Capsule should be used with caution in patients with kidney disease.
Coedhea Forte Soft Gelatin Capsule should be used with caution in patients with liver disease. Dose adjustment of Coedhea Forte Soft Gelatin Capsule may be needed. Please consult your doctor. There is very limited experience on use of Coedhea Forte Soft Gelatin Capsule in patients with underlying liver disease.
If you miss a dose of Coedhea Forte Soft Gelatin Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Signorah Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Xeno Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)